| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Regional Businesses | SVP, Regional Businesses | SVP, Group Executive Clin. Fran. +1 more
1 company
Doherty Catherine T. serves as an EVP, Regional Businesses at DGX. Across recent SEC filings that breaks down to 0 buys and 60 sells. Those positions are worth an estimated $13.8M at current prices.
Historically, Doherty Catherine T.'s trades have earned a middling insider score of 55/100 across 18 rated trades. Over a 12-month horizon, 35.3% of those trades were profitable, with an average 12-month return of -11.6%.
The biggest single holding is DGX (~$13.8M) as EVP, Regional Businesses. The recent filings there lean toward selling, a net 570,489 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 | DGX Quest Diagnostics Inc | EVP, Regional Businesses | Sell10b5-1 | 821 | $126.14 | $103,560.94 | -1.1% | +13.2% | +37.4% | |
| Mar 7, 2023 | DGX Quest Diagnostics Inc | SVP, Regional Businesses | Sell | 5,307 | $140.55 | $745,898.85 | -7.3% | -2.5% | -7.8% | |
| Mar 3, 2023 | DGX Quest Diagnostics Inc | SVP, Regional Businesses | Sell | 717 | $140.63 | $100,831.71 | -1.0% | -4.8% | -11.4% | |
| Feb 24, 2023 | DGX Quest Diagnostics Inc | SVP, Regional Businesses | Sell | 1,690 | $141.42 | $238,999.80 | -2.4% | -5.2% | -9.2% | |
| Nov 28, 2022 | DGX Quest Diagnostics Inc | SVP, Regional Businesses | Sale+OE | 40,765 | $149.18 | $6,081,261.97 | -37.6% | -7.0% | -9.0% | |
| Mar 8, 2022 | DGX Quest Diagnostics Inc | SVP, Group Executive Clin. Fran. | Sell | 7,032 | $135.21 | $950,796.72 | -9.4% | +1.6% | +3.4% | |
| Feb 24, 2022 | DGX Quest Diagnostics Inc | SVP, Group Executive Clin. Fran. | Sell | 2,750 | $126.26 | $347,215.00 | -4.1% | +9.4% | +9.7% | |
| Nov 29, 2021 | DGX Quest Diagnostics Inc | SVP, Group Executive Clin. Fran. | Sale+OE | 37,565 | $156.81 | $5,890,575.48 | -35.3% | -15.9% | -3.0% | |
| May 7, 2021 | DGX Quest Diagnostics Inc | SVP, Group Executive Clin. Fran. | Sell | 8,536 | $139.96 | $1,194,724.17 | -11.0% | +6.5% | -0.1% | |
| Sep 2, 2020 | DGX Quest Diagnostics Inc | SVP, Group Executive Clin. Fran. | Sale+OE | 58,392 | $110.60 | $6,458,342.82 | -46.0% | - | - |